Intensity Therapeutics INTS
NASDAQ INTS
$3.28 -0.01 (-0.30%)
As of: Oct 20, 2026 · 3:59 PM EDT

Intensity Therapeutics (INTS) Long-Term Debt Issuances (2023)

Updated

Intensity Therapeutics' Long-Term Debt Issuances came in at -$13,000 for Q4 2023.

Analysis

Intensity Therapeutics (INTS) Long-Term Debt Issuances (2023) Analysis & Trends

For FY2023, Intensity Therapeutics' Long-Term Debt Issuances was $230,000, down 89.8% from FY2022.

  • Going back by year, Long-Term Debt Issuances was $2.25 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Intensity Therapeutics 8.93 Mn -29.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -13,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 205,000.00
API Access

Intensity Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=INTS&period=max&api_key=YOUR_API_KEY